Anna C. Calkin

5.4k total citations · 1 hit paper
59 papers, 3.6k citations indexed

About

Anna C. Calkin is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Anna C. Calkin has authored 59 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 16 papers in Surgery and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Anna C. Calkin's work include Peroxisome Proliferator-Activated Receptors (12 papers), Lipoproteins and Cardiovascular Health (9 papers) and Cholesterol and Lipid Metabolism (8 papers). Anna C. Calkin is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (12 papers), Lipoproteins and Cardiovascular Health (9 papers) and Cholesterol and Lipid Metabolism (8 papers). Anna C. Calkin collaborates with scholars based in Australia, United States and United Kingdom. Anna C. Calkin's co-authors include Peter Tontonoz, Mark E. Cooper, Karin Jandeleit‐Dahm, Terri J. Allen, Merlin C. Thomas, Brian G. Drew, Jun Okabe, Assam El‐Osta, Josephine M. Forbes and Daniella Brasacchio and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Anna C. Calkin

56 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR

2012 591 citations Anna C. Calkin, Peter Tontonoz Nature Reviews Molecular Cell Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna C. Calkin Australia	28	1.5k	1.0k	736	564	540	59	3.6k
I. George Fantus Canada	36	2.2k 1.5×	676 0.7×	925 1.3×	489 0.9×	555 1.0×	66	4.5k
Toshiro Sugimoto Japan	41	2.1k 1.4×	610 0.6×	907 1.2×	413 0.7×	587 1.1×	100	5.3k
Ewa Ninio France	37	1.4k 0.9×	1.2k 1.1×	570 0.8×	1.0k 1.8×	417 0.8×	103	4.1k
David W. Garber United States	29	1.2k 0.8×	1.7k 1.7×	1.2k 1.6×	498 0.9×	345 0.6×	51	3.3k
Kunihisa Kobayashi Japan	32	1.5k 1.0×	604 0.6×	751 1.0×	379 0.7×	401 0.7×	106	3.6k
Baohai Shao United States	29	898 0.6×	969 0.9×	875 1.2×	760 1.3×	418 0.8×	43	2.8k
Keizo Kanasaki Japan	49	2.4k 1.6×	839 0.8×	1.3k 1.7×	645 1.1×	394 0.7×	143	6.6k
Kerry-Anne Rye Australia	25	1.0k 0.7×	1.5k 1.5×	1.3k 1.7×	415 0.7×	297 0.6×	34	3.4k
Lisa R. Tannock United States	32	1.3k 0.8×	1.1k 1.1×	841 1.1×	460 0.8×	153 0.3×	81	3.4k
Saša Frank Austria	34	1.1k 0.7×	1.0k 1.0×	611 0.8×	313 0.6×	157 0.3×	98	3.1k

Countries citing papers authored by Anna C. Calkin

Since Specialization

Citations

This map shows the geographic impact of Anna C. Calkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna C. Calkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna C. Calkin more than expected).

Fields of papers citing papers by Anna C. Calkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna C. Calkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna C. Calkin. The network helps show where Anna C. Calkin may publish in the future.

Co-authorship network of co-authors of Anna C. Calkin

This figure shows the co-authorship network connecting the top 25 collaborators of Anna C. Calkin. A scholar is included among the top collaborators of Anna C. Calkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna C. Calkin. Anna C. Calkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhuang, Aowen, Yingying Liu, Christine Yang, et al.. (2023). Deletion of the muscle enriched lncRNA Oip5os1 induces atrial dysfunction in male mice with diabetes. Physiological Reports. 11(23). e15869–e15869. 4 indexed citations

Bond, Simon T., Christine Yang, Yingying Liu, et al.. (2023). Loss of Trim28 in muscle alters mitochondrial signalling but not systemic metabolism. Journal of Endocrinology. 259(2). 2 indexed citations

Seldin, Marcus, et al.. (2023). The potential of integrating human and mouse discovery platforms to advance our understanding of cardiometabolic diseases. eLife. 12. 5 indexed citations

Bond, Simon T., Anna C. Calkin, & Brian G. Drew. (2022). Adipose-Derived Extracellular Vesicles: Systemic Messengers and Metabolic Regulators in Health and Disease. Frontiers in Physiology. 13. 837001–837001. 36 indexed citations

Keating, Michael F., Brian G. Drew, & Anna C. Calkin. (2022). Antisense Oligonucleotide Technologies to Combat Obesity and Fatty Liver Disease. Frontiers in Physiology. 13. 839471–839471. 8 indexed citations

Bond, Simon T., Darren C. Henstridge, Sarah C. Moody, et al.. (2021). Deletion of Trim28 in committed adipocytes promotes obesity but preserves glucose tolerance. Nature Communications. 12(1). 74–74. 20 indexed citations

Zhuang, Aowen, Christine Yang, Yingying Liu, et al.. (2021). SOD2 in skeletal muscle: New insights from an inducible deletion model. Redox Biology. 47. 102135–102135. 27 indexed citations

Wang, Huan, Ajay A. Vashisht, Brian G. Drew, et al.. (2021). Lipin 1 modulates mRNA splicing during fasting adaptation in liver. JCI Insight. 6(17). 9 indexed citations

Watson, Anna M.D., Sarah C. Moody, Priyadharshini Sivakumaran, et al.. (2020). Disparate Effects of Diabetes and Hyperlipidemia on Experimental Kidney Disease. Frontiers in Physiology. 11. 518–518. 4 indexed citations

10.

Ju, Lining Arnold, James D. McFadyen, Imala Alwis, et al.. (2018). Compression force sensing regulates integrin αIIbβ3 adhesive function on diabetic platelets. Nature Communications. 9(1). 1087–1087. 48 indexed citations

11.

Watson, Anna M.D., Murat Olukman, Christine Koulis, et al.. (2013). Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes. Diabetologia. 56(5). 1155–1165. 34 indexed citations

12.

Calkin, Anna C. & Peter Tontonoz. (2012). Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nature Reviews Molecular Cell Biology. 13(4). 213–224. 591 indexed citations breakdown →

13.

Weissglas‐Volkov, Daphna, Anna C. Calkin, Teresa Tusié‐Luna, et al.. (2011). The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans. Journal of Clinical Investigation. 121(8). 3062–3071. 51 indexed citations

14.

Soldatos, Georgia, Karin Jandeleit‐Dahm, H. Thomson, et al.. (2010). Large artery biomechanics and diastolic dysfunctionin patients with Type 2 diabetes. Diabetic Medicine. 28(1). 54–60. 15 indexed citations

15.

Tu, Yingfeng, Tingting Wu, Terri J. Allen, et al.. (2009). Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-β in a murine diabetic model of atherosclerosis. Diabetologia. 53(1). 170–179. 29 indexed citations

16.

Calkin, Anna C., Karin Jandeleit‐Dahm, Terri J. Allen, et al.. (2007). PPARs and Diabetes-Associated Atherosclerosis. Current Pharmaceutical Design. 13(26). 2736–2741. 6 indexed citations

17.

Calkin, Anna C., M. E. Cooper, Karin Jandeleit‐Dahm, & Terri J. Allen. (2006). Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation. Diabetologia. 49(4). 766–774. 65 indexed citations

18.

Calkin, Anna C., Sara Giunti, Karin Jandeleit‐Dahm, et al.. (2006). PPAR-α and -γ agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse. Nephrology Dialysis Transplantation. 21(9). 2399–2405. 91 indexed citations

19.

Lassila, Markus, Karin Jandeleit‐Dahm, Craig M. Smith, et al.. (2005). Imatinib Attenuates Diabetic Nephropathy in Apolipoprotein E-Knockout Mice. Journal of the American Society of Nephrology. 16(2). 363–373. 98 indexed citations

20.

Lassila, Markus, Terri J. Allen, Vicki Thallas, et al.. (2004). Accelerated Nephropathy in Diabetic Apolipoprotein E-Knockout Mouse. Journal of the American Society of Nephrology. 15(8). 2125–2138. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact